Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medivation, Inc. (MDVN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Medivation, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1011835.
Total stock buying since 2014: $3,558,800.
Total stock sales since 2014: $67,341,474.
Total stock option exercises since 2014: $4,436,290.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 0 | $0 | 112,941 | $4,589,516 | 148,814 | $538,784 |
| 2015 | 40,000 | $3,558,800 | 434,047 | $43,183,271 | 184,980 | $1,642,242 |
| 2014 | 0 | $0 | 217,256 | $19,568,687 | 240,686 | $2,255,264 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-09 | 0 | $0 | 0 | $0 | 73,814 | $286,259 |
| 2016-06 | 0 | $0 | 2,578 | $155,762 | 0 | $0 |
| 2016-05 | 0 | $0 | 10,340 | $619,516 | 0 | $0 |
| 2016-03 | 0 | $0 | 15,608 | $624,998 | 0 | $0 |
| 2016-02 | 0 | $0 | 6,350 | $197,993 | 0 | $0 |
| 2016-01 | 0 | $0 | 78,065 | $2,991,247 | 75,000 | $252,525 |
| 2015-12 | 15,000 | $610,350 | 12,025 | $518,621 | 0 | $0 |
| 2015-11 | 0 | $0 | 232 | $9,721 | 0 | $0 |
| 2015-09 | 0 | $0 | 75,080 | $3,318,455 | 71,980 | $337,802 |
| 2015-06 | 0 | $0 | 36,000 | $4,253,040 | 36,000 | $337,860 |
| 2015-05 | 0 | $0 | 5,170 | $650,603 | 0 | $0 |
| 2015-04 | 0 | $0 | 3,000 | $396,599 | 3,000 | $174,300 |
| 2015-03 | 0 | $0 | 107,631 | $13,035,455 | 2,000 | $94,960 |
| 2015-02 | 25,000 | $2,948,450 | 58,909 | $6,382,277 | 36,000 | $337,860 |
| 2015-01 | 0 | $0 | 136,000 | $14,618,500 | 36,000 | $359,460 |
| 2014-12 | 0 | $0 | 7,910 | $893,830 | 31,340 | $312,929 |
| 2014-10 | 0 | $0 | 34,346 | $3,136,531 | 34,346 | $322,578 |
| 2014-09 | 0 | $0 | 75,000 | $7,321,585 | 75,000 | $743,385 |
| 2014-08 | 0 | $0 | 65,500 | $5,589,668 | 65,500 | $612,216 |
| 2014-07 | 0 | $0 | 19,500 | $1,502,899 | 19,500 | $163,132 |
| 2014-06 | 0 | $0 | 15,000 | $1,124,174 | 15,000 | $101,024 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-21 | Blickenstaff Kim D (Director) | Option Ex | 25,500 | 2.21 | 56,355 |
| 2016-09-15 | Hirmand Mohammad (Interim Chief Medical Officer) | Option Ex | 17,560 | 4.35 | 76,350 |
| 2016-09-15 | Hung David (President and CEO) | Option Ex | 30,754 | 4.99 | 153,554 |
| 2016-06-06 | Powell Andrew Kenneth William (SVP, General Counsel & Crp Sec) | Sale | 2,578 | 60.42 | 155,762 |
| 2016-05-06 | Bierly Rick (CFO (former)) | Sale | 6,315 | 60.37 | 381,236 |
| 2016-05-05 | Bierly Rick (CFO (former)) | Sale | 4,025 | 59.20 | 238,280 |
| 2016-03-14 | Svoronos Dawn (Director) | Sale | 6,000 | 38.90 | 233,400 |
| 2016-03-04 | Hirmand Mohammad (Interim Chief Medical Officer) | Sale | 1,525 | 41.10 | 62,685 |
| 2016-03-04 | Bierly Rick (Chief Financial Officer) | Sale | 2,998 | 40.00 | 119,920 |
| 2016-03-04 | Hung David (President and CEO) | Sale | 5,085 | 41.10 | 208,993 |
| 2016-02-04 | Hung David (President and CEO) | Sale | 6,350 | 31.18 | 197,993 |
| 2016-01-19 | Machado Clarence Patrick (Director) | Sale | 75,000 | 37.98 | 2,848,725 |
| 2016-01-19 | Machado Clarence Patrick (Director) | Option Ex | 75,000 | 3.37 | 252,525 |
| 2016-01-04 | Lobacki Joseph M (Chief Commercial Officer) | Sale | 3,065 | 46.50 | 142,522 |
| 2015-12-14 | Vernon W Anthony (Director) | Buy | 15,000 | 40.69 | 610,350 |
| 2015-12-03 | Hirmand Mohammad (Interim Chief Medical Officer) | Sale | 1,075 | 43.40 | 46,655 |
| 2015-12-03 | Hung David (President and CEO) | Sale | 10,950 | 43.10 | 471,966 |
| 2015-11-09 | Hirmand Mohammad (Interim Chief Medical Officer) | Sale | 232 | 41.91 | 9,721 |
| 2015-09-25 | Machado Clarence Patrick (Director) | Sale | 71,980 | 42.26 | 3,042,090 |
| 2015-09-25 | Machado Clarence Patrick (Director) | Option Ex | 71,980 | 4.69 | 337,802 |
| 2015-09-08 | Svoronos Dawn (Director) | Sale | 3,100 | 89.15 | 276,365 |
| 2015-06-04 | Machado Clarence Patrick (Director) | Sale | 36,000 | 118.14 | 4,253,040 |
| 2015-06-04 | Machado Clarence Patrick (Director) | Option Ex | 36,000 | 9.38 | 337,860 |
| 2015-05-20 | Bierly Rick (Chief Financial Officer) | Sale | 1,000 | 130.00 | 130,000 |
| 2015-05-08 | Bierly Rick (Chief Financial Officer) | Sale | 385 | 125.00 | 48,125 |
| 2015-05-05 | Bierly Rick (Chief Financial Officer) | Sale | 1,615 | 125.00 | 201,875 |
| 2015-05-04 | Bierly Rick (Chief Financial Officer) | Sale | 2,170 | 124.70 | 270,603 |
| 2015-04-15 | Bierly Rick (Chief Financial Officer) | Sale | 3,000 | 132.20 | 396,599 |
| 2015-04-15 | Bierly Rick (Chief Financial Officer) | Option Ex | 3,000 | 58.10 | 174,300 |
| 2015-03-16 | Rhodes Jennifer J (GC & Corporate Secretary) | Sale | 1,390 | 130.92 | 181,978 |
| 2015-03-02 | Svoronos Dawn (Director) | Sale | 3,350 | 119.75 | 401,162 |
| 2015-03-02 | Rhodes Jennifer J (GC & Corporate Secretary) | Sale | 2,000 | 122.00 | 244,000 |
| 2015-03-02 | Rhodes Jennifer J (GC & Corporate Secretary) | Option Ex | 2,000 | 47.48 | 94,960 |
| 2015-03-02 | Hung David (President and CEO) | Sale | 100,891 | 121.00 | 12,208,315 |
| 2015-02-27 | Falberg Kathryn E (Director) | Buy | 25,000 | 117.94 | 2,948,450 |
| 2015-02-26 | Hung David (President and CEO) | Sale | 19,109 | 120.12 | 2,295,373 |
| 2015-02-10 | Machado Clarence Patrick (Director) | Sale | 36,000 | 102.91 | 3,704,868 |
| 2015-02-10 | Machado Clarence Patrick (Director) | Option Ex | 36,000 | 9.38 | 337,860 |
| 2015-02-04 | Rhodes Jennifer J (GC & Corporate Secretary) | Sale | 610 | 100.85 | 61,518 |
| 2015-02-04 | Hung David (President and CEO) | Sale | 3,190 | 100.48 | 320,518 |
| 2015-01-27 | Machado Clarence Patrick (Director) | Sale | 36,000 | 105.30 | 3,790,800 |
| 2015-01-27 | Machado Clarence Patrick (Director) | Option Ex | 36,000 | 9.98 | 359,460 |
| 2015-01-20 | Hung David (President and CEO) | Sale | 100,000 | 108.28 | 10,827,700 |
| 2014-12-19 | Seely Lynn (Chief Medical Officer) | Option Ex | 31,340 | 9.98 | 312,929 |
| 2014-12-03 | Rhodes Jennifer J (GC & Corporate Secretary) | Sale | 910 | 113.00 | 102,830 |
| 2014-12-03 | Machado Clarence Patrick (Director) | Sale | 1,580 | 113.00 | 178,540 |
| 2014-12-03 | Hung David (President and CEO) | Sale | 5,420 | 113.00 | 612,460 |
| 2014-10-22 | Seely Lynn (Chief Medical Officer) | Sale | 5,000 | 99.03 | 495,140 |
| 2014-10-22 | Seely Lynn (Chief Medical Officer) | Option Ex | 5,000 | 10.59 | 52,925 |
| 2014-10-16 | Seely Lynn (Chief Medical Officer) | Sale | 5,000 | 93.97 | 469,850 |
| 2014-10-16 | Seely Lynn (Chief Medical Officer) | Option Ex | 5,000 | 10.59 | 52,925 |
| 2014-10-15 | Seely Lynn (Chief Medical Officer) | Sale | 24,346 | 89.19 | 2,171,541 |
| 2014-10-15 | Seely Lynn (Chief Medical Officer) | Option Ex | 24,346 | 8.90 | 216,728 |
| 2014-09-18 | Seely Lynn (Chief Medical Officer) | Sale | 25,000 | 100.00 | 2,499,875 |
| 2014-09-18 | Seely Lynn (Chief Medical Officer) | Option Ex | 25,000 | 10.59 | 264,625 |
| 2014-09-17 | Seely Lynn (Chief Medical Officer) | Sale | 30,000 | 97.56 | 2,926,710 |
| 2014-09-17 | Seely Lynn (Chief Medical Officer) | Option Ex | 30,000 | 8.90 | 267,060 |
| 2014-09-09 | Seely Lynn (Chief Medical Officer) | Sale | 20,000 | 94.75 | 1,895,000 |
| 2014-09-09 | Seely Lynn (Chief Medical Officer) | Option Ex | 20,000 | 10.59 | 211,700 |
| 2014-08-27 | Seely Lynn (Chief Medical Officer) | Sale | 14,300 | 89.92 | 1,285,927 |
| 2014-08-27 | Seely Lynn (Chief Medical Officer) | Option Ex | 14,300 | 10.59 | 151,365 |
| 2014-08-26 | Seely Lynn (Chief Medical Officer) | Sale | 5,700 | 88.95 | 507,032 |
| 2014-08-26 | Seely Lynn (Chief Medical Officer) | Option Ex | 5,700 | 10.59 | 60,334 |
| 2014-08-13 | Seely Lynn (Chief Medical Officer) | Sale | 20,000 | 83.92 | 1,678,400 |
| 2014-08-13 | Seely Lynn (Chief Medical Officer) | Option Ex | 20,000 | 8.06 | 161,200 |
| 2014-08-12 | Seely Lynn (Chief Medical Officer) | Sale | 12,500 | 84.01 | 1,050,125 |
| 2014-08-12 | Seely Lynn (Chief Medical Officer) | Option Ex | 12,500 | 9.38 | 117,312 |
| 2014-08-08 | Seely Lynn (Chief Medical Officer) | Sale | 13,000 | 82.17 | 1,068,184 |
| 2014-08-08 | Seely Lynn (Chief Medical Officer) | Option Ex | 13,000 | 9.38 | 122,005 |
| 2014-07-22 | Seely Lynn (Chief Medical Officer) | Sale | 7,500 | 73.96 | 554,707 |
| 2014-07-22 | Seely Lynn (Chief Medical Officer) | Option Ex | 7,500 | 6.74 | 50,512 |
| 2014-07-02 | Seely Lynn (Chief Medical Officer) | Sale | 12,000 | 79.02 | 948,192 |
| 2014-07-02 | Seely Lynn (Chief Medical Officer) | Option Ex | 12,000 | 9.38 | 112,620 |
| 2014-06-18 | Seely Lynn (Chief Medical Officer) | Sale | 7,500 | 75.17 | 563,737 |
| 2014-06-18 | Seely Lynn (Chief Medical Officer) | Option Ex | 7,500 | 6.74 | 50,512 |
| 2014-06-03 | Seely Lynn (Chief Medical Officer) | Sale | 7,500 | 74.72 | 560,437 |
| 2014-06-03 | Seely Lynn (Chief Medical Officer) | Option Ex | 7,500 | 6.74 | 50,512 |
Insider trading activities including stock purchases, stock sales, and option exercises of MDVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medivation, Inc. (symbol MDVN, CIK number 1011835) see the Securities and Exchange Commission (SEC) website.